↓ Skip to main content

Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?

Overview of attention for article published in Journal of Neuro-Oncology, May 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?
Published in
Journal of Neuro-Oncology, May 2015
DOI 10.1007/s11060-015-1816-z
Pubmed ID
Authors

Michael Fay, Richard Head, Jennifer Martin

Abstract

Personalized medicine has been helpful for drug development in diseases with single and relatively stable gene mutations. The benefit for complex solid tumours with heterogeneous and changing genetic profiles is less clear. Whether it is efficient to continue diverting resources from combined biological and pharmacological approaches to trial new and existing genetic 'targeted therapies' for brain tumours is unknown but of developing concern in resource constrained environments.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 11%
Spain 1 5%
Unknown 16 84%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 26%
Professor 3 16%
Student > Doctoral Student 2 11%
Student > Postgraduate 2 11%
Researcher 1 5%
Other 1 5%
Unknown 5 26%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Agricultural and Biological Sciences 3 16%
Biochemistry, Genetics and Molecular Biology 2 11%
Neuroscience 1 5%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2015.
All research outputs
#18,411,569
of 22,807,037 outputs
Outputs from Journal of Neuro-Oncology
#2,235
of 2,968 outputs
Outputs of similar age
#192,887
of 267,111 outputs
Outputs of similar age from Journal of Neuro-Oncology
#28
of 67 outputs
Altmetric has tracked 22,807,037 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,968 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,111 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.